Counterfeit Drugs Problems and Solutions for the Indian Pharmaceutical Industry Introduction Counterfeit drugs have been around for much of the recent history of industrial-scale drug production in India and abroad. Although detailed data on counterfeit medicines are difficult to obtain by virtue of its very nature‚ a recent WHO report estimates the prevalence to be around 1% of sales in developed countries to over 10% in some developing countries1. The more important aspect of this global
Premium Pharmaceutical industry Authentication Pharmacology
Problems Faced by Small and Medium Pharmaceutical Companies Small and medium enterprises (SMEs) in their endeavour towards trans-nationalization and exports are confronted with several issues. These include: lack of expertise‚ training and finance for technological up-gradation and adoption of good manufacturing practices (GMP) by SMEs to meet global quality standards; limited exposure and expertise on IPR issues; limited adoption of information technology (IT) techniques in production and processes;
Premium Pharmacology Pharmaceutical industry Drug
INTERSCIENCE‚ B.V.: SEEKING A NEW MARKET FOR GAS CHROMATOGRAPH| B2B Marketing - Case Analysis | Submited To: Prof. S. Garimella Dated: 18th July 2010 Submitted by: Aditi Sharma Amandeep Singh Ashwini Sinha Divay Makkad Prashant Akhawat IMI | INTERSCIENCE‚ B.V.: SEEKING A NEW MARKET FOR GAS CHROMATOGRAPH | Contents 1. Introduction 3 2. Markets for gas chromatograph 3 3. Players in the contract laboratory market and the price war 4 4. Business Model of Agilent
Premium Chromatography Gas chromatography Marketing
products to the market’s specific preferences and consumers’ local tastes. Thus‚ it was the cross-country preferences of consumers that determined what products Unilever would carry. The global segment provides an enormous opportunity for Unilever. The case states that emerging country markets show the greatest potential for sales growth. Major competitors such as Procter & Gamble and Kraft Foods had sales in roughly 140 to 150 different countries in 2003‚ and Nestle‚ Unilever’s main rival‚ had market
Premium Brand Brand management
PRESENTATION ANALYSIS AND INTERPRETATION OF DATA Major Therapeutic Categories Antibiotics‚ vitamins and analgesics are the top three therapeutic classes in terms of sales by value. Anti-biotic dominate the market with approximately 24% of the market value. Vitamins and analgesics account for 6.6% and 6% of the market respectively. The vitamins and antibiotics sectors are vital not only because of their large size but also because of their astronomical growth. Sales of antibiotics are growing
Premium Pharmaceutical industry Corporation Limited company
1. Introduction The purpose of this report is to critically assess current purchasing and supply management practices in pharmaceutical industry‚ while looking at such companies as “Pfizer Inc.” and “Eli Lilly and Company”. Globalization‚ technological advances and increased worldwide competition has led to more complex supply chains in the pharmaceutical industry. It is important to acknowledge the increased exposure of these supply chains to risk. ‘The purpose of risk management is to ensure that
Premium Management Supply chain management Risk management
Medicines Company’s business model is to acquire or lease products in the development stage from leading pharmaceutical companies. Essentially‚ they will acquire or lease drugs that have been abandoned or shelved due to lack of early stage research results. The company’s success lays on their being able to save "rejected" compounds‚ receive FDA approval for their use‚ and still turn a profit. This case study provides a look at the first few years of this start-up company‚ from the initial review of abandoned
Premium Marketing Pharmacology Pharmaceutical industry
Managing The Supply Chain For Pharmaceuticals In the Public Sector | 26 avril 2011 | Aiming to guarantee the continuous flow of products from the point of manufacture to the point where they are used by consumers. | Sarita Pulton Boolell | Country & DEVELOPMENT A. Introduction The leitmotiv of the supply chain for pharmaceuticals in the Public Service is the six RIGHTS: The right pharmaceutical In the right quantity Of the right quality At the right place At the right
Premium Supply chain management
Johnson Case Analysis Introduction: Johnson and Johnson‚ commonly called J&J for short‚ is one of the world’s well known‚ largest‚ most decentralized and most diversified health care companies. Since 1887‚ Johnson and Johnson has been producing‚ manufacturing and selling products related to human health and well-being. Today J&J has over 200 autonomous operating companies and do business globally specializing in consumer products‚ medical devices and diagnostics‚ and pharmaceuticals. Consumer
Premium Pharmacology Generic drug Pharmaceutical industry
Cambridge Labs: A Case Discussion on Global Strategy Cambridge Labs: A Case Discussion on Global Strategy Successful companies that have a vision to grow beyond their domestic borders establish global strategic objectives based on their mission‚ vision and core competencies. This framework includes four major aspects‚ which help firms analyze their current status‚ the environment‚ the alternative strategies‚ and their partner selection. Cambridge Laboratories‚ an industry-based
Premium Strategic management Pharmaceutical industry